IUHSA
UTHR icon

Itau Unibanco Holding S.A.’s United Therapeutics UTHR Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-259
Closed -$54K – 640
2022
Q3 		$54K Sell
259
-137
-35% -$30.6K ﹤0.01% 381
2022
Q2 		$93K Hold
396
– – ﹤0.01% 296
2022
Q1 		$71K Hold
396
– – ﹤0.01% 287
2021
Q4 		$85K Buy
396
+13
+3% +$2.55K ﹤0.01% 233
2021
Q3 		$71K Buy
383
+136
+55% +$26.8K ﹤0.01% 228
2021
Q2 		$44K Buy
+247
New +$47K ﹤0.01% 195
2018
Q4 		– Sell
-975
Closed -$125K – 681
2018
Q3 		$125K Buy
975
+312
+47% +$38.6K 0.01% 420
2018
Q2 		$75K Sell
663
-2,122
-76% -$233K 0.01% 579
2018
Q1 		$313K Sell
2,785
-1,317
-32% -$167K ﹤0.01% 296
2017
Q4 		$607K Sell
4,102
-878
-18% -$112K 0.04% 146
2017
Q3 		$1.85M Buy
4,980
+4,670
+1,506% +$596K 0.13% 95
2017
Q2 		$40K Buy
310
+30
+11% +$3.74K ﹤0.01% 315
2017
Q1 		$38K Buy
280
+200
+250% +$30.3K ﹤0.01% 265
2016
Q4 		$11K Hold
80
– – ﹤0.01% 239
2016
Q3 		$9K Buy
+80
New +$9.61K ﹤0.01% 320

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Itau Unibanco Holding S.A.'s UTHR Position: Q4 2022 in Review

Itau Unibanco Holding S.A. sold out of United Therapeutics (UTHR) in Q4 2022, closing a stake of 259 shares — an estimated $54K sold.

Itau Unibanco Holding S.A. first reported a position in UTHR in Q3 2016 and held it in 15 quarters. The position peaked at $1.85M in Q3 2017. 511 funds tracked by Wall St. Rank hold UTHR as of Q4 2022.

  • Itau Unibanco Holding S.A. reported no remaining United Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 259 United Therapeutics shares in Q4 2022, an estimated $54K.
  • Itau Unibanco Holding S.A. first reported a position in United Therapeutics in Q3 2016 and held it in 15 quarters.
  • Itau Unibanco Holding S.A.'s United Therapeutics position peaked at $1.85M in Q3 2017.
  • 511 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2022.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2022, filed 9 Feb 2023.